Precise Design Strategies of Nanotechnologies for Controlled Drug Delivery
Source abstract
Abstract
Rapid advances in nanotechnologies are driving the revolution in controlled drug delivery. However, heterogeneous barriers, such as blood circulation and cellular barriers, prevent the drug from reaching the cellular target in complex physiologic environments. In this review, we discuss the precise design of nanotechnologies to enhance the efficacy, quality, and durability of drug delivery. For drug delivery in vivo, drugs loaded in nanoplatforms target particular sites in a spatial- and temporal-dependent manner. Advances in stimuli-responsive nanoparticles and carbon-based drug delivery platforms are summarized. For transdermal drug delivery systems, specific strategies including microneedles and hydrogel lead to a sustained release efficacy. Moreover, we highlight the current limitations of clinical translation and an incentive for the future development of nanotechnology-based drug delivery.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Advancements in Transdermal Drug Delivery · Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Oncogenes and Related Genes, Institute for Personalized Medicine, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai 200030, China
Funding
National natural science foundation of China
References (100+)
Show source-provided references
1. Recent advances of controlled drug delivery using microfluidic platforms10.1016/j.addr.2017.09.013 ↗
2. Wells, C.M., Harris, M., Choi, L., Murali, V.P., Guerra, F.D., and Jennings, J.A. (2019). Stimuli-Responsive Drug Release from Smart Polymers. J. Funct. Biomater., 10.10.3390/jfb10030034 ↗
3. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗
4. Overcoming the challenges in administering biopharmaceuticals: Formulation and delivery strategies10.1038/nrd4363 ↗
5. Controlled drug delivery vehicles for cancer treatment and their performance10.1038/s41392-017-0004-3 ↗
6. Elucidating the Influences of Size, Surface Chemistry, and Dynamic Flow on Cellular Association of Nanoparticles Made by Polymerization-Induced Self-Assembly10.1002/smll.201801702 ↗
7. Calzoni, E., Cesaretti, A., Polchi, A., Di Michele, A., Tancini, B., and Emiliani, C. (2019). Biocompatible Polymer Nanoparticles for Drug Delivery Applications in Cancer and Neurodegenerative Disorder Therapies. J. Funct. Biomater., 10.10.3390/jfb10010004 ↗
8. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
9. Larraneta, E., Stewart, S., Ervine, M., Al-Kasasbeh, R., and Donnelly, R.F. (2018). Hydrogels for Hydrophobic Drug Delivery. Classification, Synthesis and Applications. J. Funct. Biomater., 9.10.3390/jfb9010013 ↗
10. Milazzo, M., Gallone, G., Marcello, E., Mariniello, M.D., Bruschini, L., Roy, I., and Danti, S. (2020). Biodegradable Polymeric Micro/Nano-Structures with Intrinsic Antifouling/Antimicrobial Properties: Relevance in Damaged Skin and Other Biomedical Applications. J. Funct. Biomater., 11.10.3390/jfb11030060 ↗
11. Derakhshi, M., Daemi, S., Shahini, P., Habibzadeh, A., Mostafavi, E., and Ashkarran, A.A. (2022). Two-Dimensional Nanomaterials beyond Graphene for Biomedical Applications. J. Funct. Biomater., 13.10.3390/jfb13010027 ↗
12. Cell Membrane Coating Nanotechnology10.1002/adma.201706759 ↗
13. Lihumis, H., Alameri, A.A., Zaooli, R., and Chemistry, C. (2022). Design, Synthesis of Sulfadiazine Derivatives bearing Some New Heterocyclic Compounds with study Antimicrobial and Antioxidant Activity. Egypt. J. Chem.10.21608/ejchem.2022.131305.5787 ↗
14. A New Initiative on Precision Medicine10.1056/NEJMp1500523 ↗
15. Integrating Artificial Intelligence and Nanotechnology for Precision Cancer Medicine
16. 2′-O-Methyl modified guide RNA promotes the single nucleotide polymorphism (SNP) discrimination ability of CRISPR-Cas12a systems10.1039/D1SC06832F ↗
17. Integrated microfluidic single-cell immunoblotting chip enables high-throughput isolation, enrichment and direct protein analysis of circulating tumor cells10.1038/s41378-021-00342-2 ↗
18. Sickle-like Inertial Microfluidic System for Online Rare CellSeparation and Tandem Label-Free Quantitative Proteomics (Orcs-Proteomics)10.1021/acs.analchem.2c00679 ↗
19. The entry of nanoparticles into solid tumours10.1038/s41563-019-0566-2 ↗
20. trans-Golgi network-bound cargo traffic10.1016/j.ejcb.2018.01.003 ↗
21. Concepts of nanoparticle cellular uptake, intracellular trafficking, and kinetics in nanomedicine10.1016/j.addr.2019.04.008 ↗
22. Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination10.1016/j.jconrel.2016.01.020 ↗
23. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles10.1016/j.ijpharm.2005.10.010 ↗
24. Renal clearance of quantum dots10.1038/nbt1340 ↗
25. Quantification of Whole Body and Excreted Carbon Nanohorns Intravenously Injected into Mice10.1002/adhm.201300192 ↗
26. Secretion of intestinal goblet cells: A novel excretion pathway of nanoparticles10.1016/j.nano.2013.10.004 ↗
27. PEGylation as a strategy for improving nanoparticle-based drug and gene delivery10.1016/j.addr.2015.09.012 ↗
28. Analysis of nanoparticle delivery to tumours10.1038/natrevmats.2016.14 ↗
29. Detachment of ligands from nanoparticle surface under flow and endothelial cell contact: Assessment using microfluidic devices10.1002/btm2.10089 ↗
30. Shear Stress and Its Effect on the Interaction of Myoblast Cells with Nanosized Drug Delivery Vehicles10.1021/mp4001298 ↗
31. Biomaterial based modulation of macrophage polarization: A review and suggested design principles10.1016/j.mattod.2015.01.019 ↗
32. The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction10.2217/nnm.16.5 ↗
33. Contribution of high-resolution correlative imaging techniques in the study of the liver sieve in three-dimensions10.1002/jemt.20408 ↗
34. A minimal physiologically based pharmacokinetic model that predicts anti-PEG IgG-mediated clearance of PEGylated drugs in human and mouse10.1016/j.jconrel.2018.06.002 ↗
35. Analysis of Pre-existing IgG and IgM Antibodies against Polyethylene Glycol (PEG) in the General Population10.1021/acs.analchem.6b03437 ↗
36. Shape effects of filaments versus spherical particles in flow and drug delivery10.1038/nnano.2007.70 ↗
37. Shape and Orientation Matter for the Cellular Uptake of Nonspherical Particles10.1021/nl403949h ↗
38. Cellular uptake of nanoparticles: Journey inside the cell10.1039/C6CS00636A ↗
39. Size-Dependent Cellular Uptake and Expulsion of Single-Walled Carbon Nanotubes: Single Particle Tracking and a Generic Uptake Model for Nanoparticles10.1021/nn800532m ↗
40. A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles10.1038/nnano.2009.195 ↗
41. Controlling the Localization of Polymer-Functionalized Nanoparticles in Mixed Lipid/Polymer Membranes10.1021/nn3023602 ↗
42. Elasticity of Nanopartides Influences Their Blood Circulation, Phagocytosis, Endocytosis, and Targeting10.1021/acsnano.5b00147 ↗
43. DNA Nanotechnology-Enabled Drug Delivery Systems10.1021/acs.chemrev.7b00663 ↗
44. Nanoparticles of Metal-Organic Frameworks: On the Road to In Vivo Efficacy in Biomedicine10.1002/adma.201707365 ↗
45. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
46. Thermo- and pH-responsive polymers in drug delivery10.1016/j.addr.2006.09.020 ↗
47. Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression10.1016/j.cell.2015.08.016 ↗
48. Extracellular matrix structure10.1016/j.addr.2015.11.001 ↗
49. Hyaluronan and tumor growth10.1016/S0002-9440(10)64232-0 ↗
50. Highly enhanced cancer immunotherapy by combining nanovaccine with hyaluronidase10.1016/j.biomaterials.2018.04.039 ↗
51. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment
52. Hyaluronidase with pH-responsive Dextran Modification as an Adjuvant Nanomedicine for Enhanced Photodynamic-Immunotherapy of Cancer10.1002/adfm.201902440 ↗
53. pH-sensitive bromelain nanoparticles by ortho ester crosslinkage for enhanced doxorubicin penetration in solid tumor10.1016/j.msec.2020.111004 ↗
54. Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex10.1016/j.biomaterials.2017.07.030 ↗
55. Human-Body-Temperature Triggerable Phase Transition of W-VO2@PEG Nanoprobes with Strong and Switchable NIR-II Absorption for Deep and Contrast-Enhanced Photoacoustic Imaging10.1021/acsnano.1c07511 ↗
56. Multifunctional Nanoparticle Loaded Injectable Thermoresponsive Hydrogel as NIR Controlled Release Platform for Local Photothermal Immunotherapy to Prevent Breast Cancer Postoperative Recurrence and Metastases10.1002/adfm.202001059 ↗
57. Multifunctional Bismuth Selenide Nanocomposites for Antitumor Thermo-Chemotherapy and Imaging10.1021/acsnano.5b06259 ↗
58. Near-infrared light-controllable on-demand antibiotics release using thermo-sensitive hydrogel-based drug reservoir for combating bacterial infection10.1016/j.biomaterials.2018.09.045 ↗
59. Opposing Temperature Dependence of the Stretching Response of Single PEG and PNiPAM Polymers10.1021/jacs.9b04383 ↗
60. Cathepsin B-responsive nanodrug delivery systems for precise diagnosis and targeted therapy of malignant tumors10.1016/j.cclet.2020.05.027 ↗
61. A thermoresponsive nanocarrier for mitochondria-targeted drug delivery10.1039/C9CC00603F ↗
62. Thermoresponsive drug delivery to mitochondria in vivo10.1039/C9CC07538K ↗
63. Mitochondrial temperature-responsive drug delivery reverses drug resistance in lung cancer
64. Photoresponsive nanoparticles for drug delivery10.1016/j.nantod.2015.06.004 ↗
65. Near-Infrared-Light-Activatable Nanomaterial-Mediated Phototheranostic Nanomedicines: An Emerging Paradigm for Cancer Treatment10.1002/adma.201706320 ↗
66. A Red Light-Triggered Drug Release System Based on One-Photon Upconversion-Like Photolysis10.1002/adhm.202001118 ↗
67. Green Light-Triggered Intraocular Drug Release for Intravenous Chemotherapy of Retinoblastoma10.1002/advs.202101754 ↗
68. Intravenous treatment of choroidal neovascularization by photo-targeted nanoparticles10.1038/s41467-019-08690-4 ↗
69. Sequential activation and deactivation of protein function using spectrally differentiated caged phosphoamino acids10.1021/ja2028074 ↗
70. Two-color, two-photon uncaging of glutamate and GABA10.1038/nmeth.1413 ↗
71. Light-Triggered Efficient Sequential Drug Delivery of Biomimetic Nanosystem for Multimodal Chemo-, Antiangiogenic, and Anti-MDSC Therapy in Melanoma10.1002/adma.202106682 ↗
72. Light-Triggered Drug Release from 3D-Printed Magnetic Chitosan Microswimmers10.1021/acsnano.8b05997 ↗
73. A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells10.1038/s41565-020-00793-0 ↗
74. Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia10.1016/j.ccell.2014.10.006 ↗
75. Glutathione- and light-controlled generation of singlet oxygen for triggering drug release in mesoporous silica nanoparticles10.1039/D0TB00636J ↗
76. Multi-stimuli responsive macromolecules and their assemblies10.1039/c3cs60094g ↗
77. Self-Cross-Linked Polymer Nanogels: A Versatile Nanoscopic Drug Delivery Platform10.1021/ja1069932 ↗
78. Enzyme-responsive nanoparticles for drug release and diagnostics10.1016/j.addr.2012.01.002 ↗
79. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents10.1016/j.jconrel.2015.10.040 ↗
80. Polymeric delivery systems for nucleic acid therapeutics: Approaching the clinic10.1016/j.jconrel.2021.01.014 ↗
81. Collagenase Nanoparticles Enhance the Penetration of Drugs into Pancreatic Tumors10.1021/acsnano.9b02395 ↗
82. Effective Delivery of the CRISPR/Cas9 System Enabled by Functionalized Mesoporous Silica Nanoparticles for GFP-Tagged Paxillin Knock-In10.1002/adtp.202000072 ↗
83. A novel signal-on photoelectrochemical immunosensor for detection of alpha-fetoprotein by in situ releasing electron donor10.1016/j.bios.2017.06.047 ↗
84. A combinational chemo-immune therapy using an enzyme-sensitive nanoplatform for dual-drug delivery to specific sites by cascade targeting10.1126/sciadv.aba0776 ↗
85. Quantum dot bioconjugates for imaging, labelling and sensing10.1038/nmat1390 ↗
86. Protease-Sensitive, Polymer-Caged Liposomes: A Method for Making Highly Targeted Liposomes Using Triggered Release10.1021/nn103362n ↗
87. A HiPAD Integrated with rGO/MWCNTs Nano-Circuit Heater for Visual Point-of-Care Testing of SARS-CoV-210.1002/adfm.202100801 ↗
88. Encountering and Wrestling: Neutrophils Recognize and Defensively Degrade Graphene Oxide10.1002/adhm.202102439 ↗
89. Functional Carbon Quantum Dots as Medical Countermeasures to Human Coronavirus10.1021/acsami.9b15032 ↗
90. Graphene-Based Smart Platforms for Combined Cancer Therapy10.1002/adma.201800662 ↗
91. Fluorinated Graphene Oxide; a New Multimodal Material for Biological Applications10.1002/adma201301804 ↗
92. The chemistry of graphene oxide10.1039/B917103G ↗
93. Chemistry and Structure of Graphene Oxide via Direct Imaging10.1021/acsnano.6b02391 ↗
94. Preparation and characterization of graphene oxide paper10.1038/nature06016 ↗
95. Deep Tissue Translocation of Graphene Oxide Sheets in Human Glioblastoma 3D Spheroids and an Orthotopic Xenograft Model10.1002/adtp.202000109 ↗
96. Erythrocyte membrane camouflaged graphene oxide for tumor-targeted photothermal-chemotherapy10.1016/j.carbon.2019.02.056 ↗
97. Oxidation of Reduced Graphene Oxide via Cellular Redox Signaling Modulates Actin-Mediated Neurotransmission10.1021/acsnano.9b08078 ↗
98. Efficient Lymph Node-Targeted Delivery of Personalized Cancer Vaccines with Reactive Oxygen Species-Inducing Reduced Graphene Oxide Nanosheets10.1021/acsnano.0c05062 ↗
99. Membrane fusion and drug delivery with carbon nanotube porins10.1073/pnas.2016974118 ↗
100. Transformable Honeycomb-Like Nanoassemblies of Carbon Dots for Regulated Multisite Delivery and Enhanced Antitumor Chemoimmunotherapy10.1002/anie.202014397 ↗